OpenVSafe by OpenVAERS
Search V-safe

PD5-24666-64596

2 vaccinations 3 coded responses 12 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
263 / WV
Registered
2022-01-22
Relationship
Child or adolescent in my care
Guardian
EBR-19950-55037
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-12-28
    Dose 1 — Pfizer-BioNTech
  2. 2022-01-18
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-22
    Registered in v-safe
  4. 2022-01-22
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2022-01-23
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2022-01-24
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  7. 2022-01-25
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · Headache
    Adult check-in
  8. 2022-02-01
    Survey response — day 14, dose 2, dependent
    MedDRA: Headache — Feeling: Good
    Free text: Headaches that have been more frequent
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-02-11
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  10. 2022-02-15
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  11. 2022-02-22
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  12. 2022-03-01
    Survey response — day 42, dose 2, dependent
    MedDRA: Nasal congestion, Sinus congestion — Feeling: Fair
    Free text: Sinus congestion, stuffy nose
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-04-19
  14. 2022-07-19
  15. 2023-01-19
    Survey response — 12 months, dose 2, dependent
    MedDRA: Unevaluable event — Feeling: Good
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-12-28Pfizer-BioNTech No
22022-01-18Pfizer-BioNTech No

Free text

Release 11 — day 14, dose 2, dependent

2022-02-01

Symptoms: Headaches that have been more frequent

Release 11 — day 42, dose 2, dependent

2022-03-01

Symptoms: Sinus congestion, stuffy nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓
SDNasal congestion · · ✓
SDSinus congestion · · ✓
SDUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release